Evidence for the Use of Secukinumab in Patients with Radiographic and Non-radiographic Axial Spondyloarthritis in the Last 5 Years
In conclusion, secukinumab is a largely safe and effective treatment for radiographic and non-radiographic axSpA.
Source: Rheumatology and Therapy - Category: Rheumatology Source Type: research
More News: Arthritis | Back Pain | Chronic Pain | Clinical Trials | Coronavirus | COVID-19 | Genetics | Humira | Pain | Pandemics | Radiography | Respiratory Medicine | Rheumatology | SARS | Study